| Insider | Role | Holdings | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| David V Elkins | EVP, Chief Financial Officer | 159,248 | — | $4,500,496 | -$4,500,496 |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | 83,513 | $402,270 | — | $402,270 |
| Christopher S. Boerner | Chief Executive Officer, Director | 21,451 | $110,096 | — | $110,096 |
| Phil M Holzer | SVP and Controller | 16,862 | — | $72,680 | -$72,680 |
| Bartie Wendy Short | EVP, Corporate Affairs | 12,081 | — | $16,719 | -$16,719 |
| Benjamin Hickey | President, RayzeBio Org. | 16,672 | — | $3,702 | -$3,702 |
| Date | Insider | Side | Shares | Price | Value | Holdings After | % of Position |
|---|---|---|---|---|---|---|---|
| 2026-08-25 | Phil M Holzer | SELL | 500 | $67.50 | $33,750 | 16,862 | 3% |
| 2026-04-01 | David V Elkins | SELL | 25,519 | $61.60 | $1,571,970 | 163,729 | 13% |
| 2026-04-01 | David V Elkins | SELL | 4,481 | $62.05 | $278,046 | 159,248 | 3% |
| 2025-09-02 | David V Elkins | SELL | 56,000 | $47.33 | $2,650,480 | 167,379 | 25% |
| 2025-08-02 | Bartie Wendy Short | SELL | 378 | $44.23 | $16,719 | 5,066 | 7% |
| 2025-05-09 | Benjamin Hickey | SELL | 97 | $38.01 | $3,702 | 0 | 100% |
| 2025-04-25 | Samit Hirawat | BUY | 4,250 | $47.58 | $202,215 | 83,513 | 5% |
| 2025-02-20 | Christopher S. Boerner | BUY | 2,000 | $55.05 | $110,096 | 104,626 | 2% |
| 2025-02-14 | Samit Hirawat | BUY | 1,823 | $54.84 | $100,000 | 63,932 | 3% |
| 2024-11-04 | Phil M Holzer | SELL | 700 | $55.62 | $38,930 | 11,760 | 6% |
| 2024-11-01 | Samit Hirawat | BUY | 1,830 | $54.67 | $100,055 | 62,109 | 3% |